Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2002 Dec;78(6):440–444. doi: 10.1136/sti.78.6.440

Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India

U Chaudhry 1, K Ray 1, M Bala 1, D Saluja 1
PMCID: PMC1758340  PMID: 12473806

Abstract

Aim: To analyse mutations in the gyrA and parC genes leading to possible increase in ciprofloxacin resistance (high MIC values for ciprofloxacin) in clinical isolates of Neisseria gonorrhoeae in Delhi, India.

Method: MIC of ciprofloxacin for 63 clinical isolates of N gonorrhoeae were examined by the Etest method. Subsequently, gyrA and parC genes of these isolates were amplified and sequenced for possible mutations.

Results: Out of the 63 clinical isolates tested, only five (8%) isolates were found to be susceptible to ciprofloxacin (MIC <0.06 µg/ml). DNA sequence analysis of the gyrA and the parC genes of all these isolates (n = 63) revealed that all isolates which were not susceptible to ciprofloxacin (n=58) had mutation(s) in gyrA and parC genes. 12 isolates (19%) exhibited high resistance with an MIC for ciprofloxacin of 32 µg/ml. Two out of these 12 isolates (UD62 and UD63), harboured triple mutations (Ser-91 to Phe, Asp-95 to Asn and Val-120 to Leu) in the gyrA gene. The third mutation of Val-120 to Leu, lies downstream of the quinolone resistance determining region (QRDR) of the gyrA and has not been described before in gonococcus. In addition, both these isolates had a Phe-100 to Tyr substitution in the parC, a hitherto unknown mutation.

Conclusions: Emergence of ciprofloxacin resistance with high levels of MIC values (up to 32 µg/ml) in India is alarming. Double and triple mutations in gyrA alone or together in gyrA and parC could be responsible for such a high resistance.

Full Text

The Full Text of this article is available as a PDF (161.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belland R. J., Morrison S. G., Ison C., Huang W. M. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol. 1994 Oct;14(2):371–380. doi: 10.1111/j.1365-2958.1994.tb01297.x. [DOI] [PubMed] [Google Scholar]
  2. Bhalla P., Sethi K., Reddy B. S., Mathur M. D. Antimicrobial susceptibility and plasmid profile of Neisseria gonorrhoeae in India (New Delhi). Sex Transm Infect. 1998 Jun;74(3):210–212. doi: 10.1136/sti.74.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bhuiyan B. U., Rahman M., Miah M. R., Nahar S., Islam N., Ahmed M., Rahman K. M., Albert M. J. Antimicrobial susceptibilities and plasmid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: emergence of high-level resistance to ciprofloxacin. J Clin Microbiol. 1999 Apr;37(4):1130–1136. doi: 10.1128/jcm.37.4.1130-1136.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deguchi T., Yasuda M., Asano M., Tada K., Iwata H., Komeda H., Ezaki T., Saito I., Kawada Y. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1995 Feb;39(2):561–563. doi: 10.1128/aac.39.2.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Deguchi T., Yasuda M., Nakano M., Ozeki S., Ezaki T., Maeda S., Saito I., Kawada Y. Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones. J Clin Microbiol. 1996 Sep;34(9):2255–2258. doi: 10.1128/jcm.34.9.2255-2258.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Deguchi T., Yasuda M., Nakano M., Ozeki S., Ezaki T., Saito I., Kawada Y. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob Agents Chemother. 1996 Apr;40(4):1020–1023. doi: 10.1128/aac.40.4.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drlica K., Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997 Sep;61(3):377–392. doi: 10.1128/mmbr.61.3.377-392.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fox K. K., Knapp J. S., Holmes K. K., Hook E. W., 3rd, Judson F. N., Thompson S. E., Washington J. A., Whittington W. L. Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis. 1997 Jun;175(6):1396–1403. doi: 10.1086/516472. [DOI] [PubMed] [Google Scholar]
  9. Hallett P., Maxwell A. Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteins. Antimicrob Agents Chemother. 1991 Feb;35(2):335–340. doi: 10.1128/aac.35.2.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ison C. A., Woodford P. J., Madders H., Claydon E. Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure. Antimicrob Agents Chemother. 1998 Nov;42(11):2919–2922. doi: 10.1128/aac.42.11.2919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Knapp J. S., Hale J. A., Neal S. W., Wintersheid K., Rice R. J., Whittington W. L. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. Antimicrob Agents Chemother. 1995 Nov;39(11):2442–2445. doi: 10.1128/aac.39.11.2442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lee K., Shin J. W., Lim J. B., Kim Y. A., Yong D., Oh H. B., Chong Y. Emerging antimicrobial resistance, plasmid profile and pulsed-field gel electrophoresis pattern of the endonuclease-digested genomic DNA of Neisseria gonorrhoeae. Yonsei Med J. 2000 Jun;41(3):381–386. doi: 10.3349/ymj.2000.41.3.381. [DOI] [PubMed] [Google Scholar]
  13. Lee Kyungwon, Chong Yunsop, Erdenechemeg L., Soon Song Kyung, Hun Shin Kwang. Incidence, epidemiology and evolution of reduced susceptibility to ciprofloxacin in Neisseria gonorrhoeae in Korea. Clin Microbiol Infect. 1998 Jan;4(11):627–633. doi: 10.1111/j.1469-0691.1998.tb00345.x. [DOI] [PubMed] [Google Scholar]
  14. Lee S., Lee Y. Ofloxacin resistance mechanism in PA150 and PA300-clinical isolates of Pseudomonas aeruginosa in Korea. Arch Pharm Res. 1998 Dec;21(6):671–676. doi: 10.1007/BF02976755. [DOI] [PubMed] [Google Scholar]
  15. Mavroidi A., Tzouvelekis L. S., Tassios P. T., Flemetakis A., Daniilidou M., Tzelepi E. Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999. J Clin Microbiol. 2000 Sep;38(9):3489–3491. doi: 10.1128/jcm.38.9.3489-3491.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pai A., Kulkarni M. G., Koppikar G. V. Antibiotics sensitivity pattern of N. gonorrhoeae with special emphasis on norfloxacin and ciprofloxacin. J Assoc Physicians India. 1999 Aug;47(8):795–797. [PubMed] [Google Scholar]
  17. Rattan A., Kumari S., Khanna N., Pandhi R. K., Ray K., Bala M., Misra R. S. Emergence of fluoroquinolone resistant Neisseria gonorrhoeae in New Delhi, India. Sex Transm Infect. 1998 Jun;74(3):229–229. [PubMed] [Google Scholar]
  18. Ray K., Bala M., Kumar J., Misra R. S. Trend of antimicrobial resistance in Neisseria gonorrhoeae at New Delhi, India. Int J STD AIDS. 2000 Feb;11(2):115–118. doi: 10.1177/095646240001100209. [DOI] [PubMed] [Google Scholar]
  19. Stein D. C., Danaher R. J., Cook T. M. Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1991 Apr;35(4):622–626. doi: 10.1128/aac.35.4.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tanaka M., Nakayama H., Haraoka M., Saika T. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998. J Clin Microbiol. 2000 Feb;38(2):521–525. doi: 10.1128/jcm.38.2.521-525.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tanaka M., Nakayama H., Haraoka M., Saika T., Kobayashi I., Naito S. Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoroquinolones and other antibiotics. Antimicrob Agents Chemother. 2000 Jan;44(1):192–195. doi: 10.1128/aac.44.1.192-195.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Trees D. L., Sandul A. L., Neal S. W., Higa H., Knapp J. S. Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999. Sex Transm Dis. 2001 Jun;28(6):309–314. doi: 10.1097/00007435-200106000-00001. [DOI] [PubMed] [Google Scholar]
  23. Trees D. L., Sandul A. L., Whittington W. L., Knapp J. S. Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1998 Aug;42(8):2103–2105. doi: 10.1128/aac.42.8.2103. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES